Beta-adrenergic effects on cellular cholesterologenesis and low density lipoprotein metabolism.
Owens
D
D
Department of Biochemistry Royal College of Surgeons in Ireland.
O'Donnell
L
L
Collins
P
P
Johnson
A
A
Tomkin
G H
GH
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D002784:Cholesterol / Q000097:blood*; D006801:Humans; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology*; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000097:blood*; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism*; D011412:Propanolamines / Q000494:pharmacology*; D011973:Receptors, LDL / Q000378:metabolism; D012016:Reference Values
D000319:Adrenergic beta-Antagonists; D008077:Lipoproteins, LDL; D011412:Propanolamines; D011973:Receptors, LDL; D002784:Cholesterol; D007545:Isoproterenol; C033394:CGP 12177